Tumors of the Central Nervous System, Volume 1
Home > Medicine & Health Science textbooks > Clinical and internal medicine > Diseases and disorders > Oncology > Tumors of the Central Nervous System, Volume 1: Gliomas: Glioblastoma (Part 1)
Tumors of the Central Nervous System, Volume 1: Gliomas: Glioblastoma (Part 1)

Tumors of the Central Nervous System, Volume 1: Gliomas: Glioblastoma (Part 1)

|
     0     
5
4
3
2
1




International Edition


About the Book

The most recent developments in diagnostic and therapeutic aspects of Gliomas (Glioblastoma) in the brain are presented. The importance of personalized medicine and clinical validation for targeted therapy are discussed. The identification of various types of biomarkers is included. The identification and validation of brain cancer (glioblastoma) genes are discussed. Role of cancer stem cells in the initiation, progression, and persistence of malignant gliomas is explained. The use of surgical resection, chemotherapy (e.g., temozolomide), immunotherapy, and radiotherapy for malignant glioblastoma are pointed out. Standard (established) as well as newer imaging modalities (proton magnetic resonance spectroscopy) are discussed.

Table of Contents:
Introduction. 1. introduction. 2. molecular classification of gliomas. i.biomarkers and diagnosis.  3. glioblastoma: endosialin marker for pericytes. 4. glioma grading using cerebral blood volume heterogeneity. 5. the role of ectonucleotidases in glioma cell proliferation. 6. gliomas: role of monoamine oxidase b in diagnosis. 7. glioma: role of integrin in pathogenesis and therapy. 8. proton magnetic resonance spectroscopy in intracranial gliomas. 9. infiltration zone in glioma: proton magnetic resonance spectroscopic imaging. 10. malignant gliomas: role of e2f1 trascription factor. 11. the role of glucose transporter-1 (glut-1) in malignant gliomas. 12. malignant gliomas: role of platelet-derived growth factor receptor a (pdgfra).  13. molecular methods for detection of tumor markers in glioblastoma. 14. role of mgmt in globlastoma. 15. glioblastomas: role of cxcl12 chemokine. 16. cell death signaling in glioblastoma multiforme: role of the bcl2l12 oncoprotein. 17. glioblastoma multiforme: role of polycomb group proteins. 18. glioblastoma multiforme: role of cell cycle-related kinase protein (method). ii.neural stem cells and cancer stem cells. 19. markers of stem cells in gliomas. 20. efficient derivation and propagation of glioblastoma stem-like cells under serum-free conditions using the cambrige protocol. 21. glioma cell lines: role of cancer stem cells. 22. glioblastoma cancer stem cells: response to epidermal growth factor receptor kinase inhibitors. iii.therapy. 23. low-and high-grade gliomas: extensive surgical resection. 24. brainstem gangliogliomas: total resection and close follow-up. 25. glioblastoma: temozolomide-based chemotherapy. 26. drug-resistant glioma: treatment with imatinib mesylate      and chlorimipramine. 27. glioblastoma multiforme: molecular basis of resistance to erlotinib. 28. enhanced glioma chemosensitivity. 29. malignant glioma patients: anti-vascularendothelial  growth factor monoclonal antibody, bevacizumab. 30. aggravating endoplasmic reticulum stress by combined application of bortezomib and celecoxib as a novel therapeutic strategy for glioblastoma. 31. targeted therapy for malignant glimas. 32. glioblastomas: her1/egfr-targeted therapeutics.33. epidermal growth factor receptor inhibition as a therapeutic strategy for glioblastoma multiforme.  34: role of acyl-coa symthetases in glioma cell survival and its therapeutic implication. 35. maglignant glioma patients: combined treatment with radiation and fotemustine. 36. malignant glioma immunotherapy: a peptide vaccince from bench to bedside. 37. malignant glioma: chemovirotherapy. 38. intracranial glioma: delivery of an oncolytic adenovirus. 39. use of magnetic resonance spectroscopy imaging (mrsi) in the treatment planning of gliomas. 40. malignant glima cells: role of trail-induced apoptosis. iv.prognosis. 41. long-term survivors of glioblastoma. 42. glioblastoma patients: p15 methylation as a prognostic factor.


Best Sellers


Product Details
  • ISBN-13: 9789400703438
  • Publisher: Springer
  • Publisher Imprint: Springer
  • Height: 260 mm
  • No of Pages: 434
  • Sub Title: Gliomas: Glioblastoma (Part 1)
  • ISBN-10: 9400703430
  • Publisher Date: 23 Mar 2011
  • Binding: Hardback
  • Language: English
  • Returnable: Y
  • Width: 193 mm


Similar Products

Add Photo
Add Photo

Customer Reviews

REVIEWS      0     
Click Here To Be The First to Review this Product
Tumors of the Central Nervous System, Volume 1: Gliomas: Glioblastoma (Part 1)
Springer -
Tumors of the Central Nervous System, Volume 1: Gliomas: Glioblastoma (Part 1)
Writing guidlines
We want to publish your review, so please:
  • keep your review on the product. Review's that defame author's character will be rejected.
  • Keep your review focused on the product.
  • Avoid writing about customer service. contact us instead if you have issue requiring immediate attention.
  • Refrain from mentioning competitors or the specific price you paid for the product.
  • Do not include any personally identifiable information, such as full names.

Tumors of the Central Nervous System, Volume 1: Gliomas: Glioblastoma (Part 1)

Required fields are marked with *

Review Title*
Review
    Add Photo Add up to 6 photos
    Would you recommend this product to a friend?
    Tag this Book Read more
    Does your review contain spoilers?
    What type of reader best describes you?
    I agree to the terms & conditions
    You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.

    CUSTOMER RATINGS AND REVIEWS AND QUESTIONS AND ANSWERS TERMS OF USE

    These Terms of Use govern your conduct associated with the Customer Ratings and Reviews and/or Questions and Answers service offered by Bookswagon (the "CRR Service").


    By submitting any content to Bookswagon, you guarantee that:
    • You are the sole author and owner of the intellectual property rights in the content;
    • All "moral rights" that you may have in such content have been voluntarily waived by you;
    • All content that you post is accurate;
    • You are at least 13 years old;
    • Use of the content you supply does not violate these Terms of Use and will not cause injury to any person or entity.
    You further agree that you may not submit any content:
    • That is known by you to be false, inaccurate or misleading;
    • That infringes any third party's copyright, patent, trademark, trade secret or other proprietary rights or rights of publicity or privacy;
    • That violates any law, statute, ordinance or regulation (including, but not limited to, those governing, consumer protection, unfair competition, anti-discrimination or false advertising);
    • That is, or may reasonably be considered to be, defamatory, libelous, hateful, racially or religiously biased or offensive, unlawfully threatening or unlawfully harassing to any individual, partnership or corporation;
    • For which you were compensated or granted any consideration by any unapproved third party;
    • That includes any information that references other websites, addresses, email addresses, contact information or phone numbers;
    • That contains any computer viruses, worms or other potentially damaging computer programs or files.
    You agree to indemnify and hold Bookswagon (and its officers, directors, agents, subsidiaries, joint ventures, employees and third-party service providers, including but not limited to Bazaarvoice, Inc.), harmless from all claims, demands, and damages (actual and consequential) of every kind and nature, known and unknown including reasonable attorneys' fees, arising out of a breach of your representations and warranties set forth above, or your violation of any law or the rights of a third party.


    For any content that you submit, you grant Bookswagon a perpetual, irrevocable, royalty-free, transferable right and license to use, copy, modify, delete in its entirety, adapt, publish, translate, create derivative works from and/or sell, transfer, and/or distribute such content and/or incorporate such content into any form, medium or technology throughout the world without compensation to you. Additionally,  Bookswagon may transfer or share any personal information that you submit with its third-party service providers, including but not limited to Bazaarvoice, Inc. in accordance with  Privacy Policy


    All content that you submit may be used at Bookswagon's sole discretion. Bookswagon reserves the right to change, condense, withhold publication, remove or delete any content on Bookswagon's website that Bookswagon deems, in its sole discretion, to violate the content guidelines or any other provision of these Terms of Use.  Bookswagon does not guarantee that you will have any recourse through Bookswagon to edit or delete any content you have submitted. Ratings and written comments are generally posted within two to four business days. However, Bookswagon reserves the right to remove or to refuse to post any submission to the extent authorized by law. You acknowledge that you, not Bookswagon, are responsible for the contents of your submission. None of the content that you submit shall be subject to any obligation of confidence on the part of Bookswagon, its agents, subsidiaries, affiliates, partners or third party service providers (including but not limited to Bazaarvoice, Inc.)and their respective directors, officers and employees.

    Accept

    New Arrivals

    Inspired by your browsing history


    Your review has been submitted!

    You've already reviewed this product!